Circular RNA circ-LDLRAD3 serves as an oncogene to promote non-small cell lung cancer progression by upregulating SLC1A5 through sponging miR-137

References

• Harrison PT, Vyse S, Huang PH. Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer. Semin Cancer Biol. 2019;61:167–179.
   PubMed Web of Science ®Google Scholar
• Lou B, Wei D, Zhou X, et al. Long non-coding RNA KDM5B anti-sense RNA 1 enhances tumor progression in non-small cell lung cancer. J Clin Lab Anal. 2019;34(1):e22897.
   Web of Science ®Google Scholar
• Wang M, Mao C, Ouyang L, et al. Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA. Cell Death Differ. 2019;26(11):2329–2343.
   Web of Science ®Google Scholar
• Hellmann MD, Paz-Ares L, Bernabe Caro R, et al. Nivolumab plus Ipilimumab in advanced non-small-cell lung cancer. N Engl J Med. 2019;381(21):2020–2031. DOI:10.1056/NEJMoa1910231.
   PubMed Web of Science ®Google Scholar
• van Timmeren JE, van Elmpt W, de Ruysscher D, et al. Tumor regression during radiotherapy for non-small cell lung cancer patients using cone-beam computed tomography images. Strahlenther Onkol. 2019;196(2):159–171.
   PubMed Web of Science ®Google Scholar
• Visser S, Koolen SLW, de Bruijn P, et al. Pemetrexed exposure predicts toxicity in advanced non-small-cell lung cancer: A prospective cohort study. Eur J Cancer. 2019;121:64–73.
   PubMed Web of Science ®Google Scholar
• Jin M, Shi C, Yang C, et al. Upregulated circRNA ARHGAP10 predicts an unfavorable prognosis in NSCLC through regulation of the miR-150-5p/GLUT-1 axis. Mol Ther Nucleic Acids. 2019;18:219–231.
   PubMedGoogle Scholar
• Liu C, Zhang Z, Qi D. Circular RNA hsa_circ_0023404 promotes proliferation, migration and invasion in non-small cell lung cancer by regulating miR-217/ZEB1 axis. Onco Targets Ther. 2019;12:6181–6189.
   PubMed Web of Science ®Google Scholar
• Liu YT, Han X-H, Xing P-Y, et al. Circular RNA profiling identified as a biomarker for predicting the efficacy of Gefitinib therapy for non-small cell lung cancer. J Thorac Dis. 2019;11(5):1779–1787. DOI:10.21037/jtd.2019.05.22.
   PubMed Web of Science ®Google Scholar
• Wang Y, Li Y, He H, et al. Circular RNA circ-PRMT5 facilitates non-small cell lung cancer proliferation through upregulating EZH2 via sponging miR-377/382/498. Gene. 2019;720:144099.
   PubMed Web of Science ®Google Scholar
• Wei S, Zheng Y, Jiang Y, et al. The circRNA circPTPRA suppresses epithelial-mesenchymal transitioning and metastasis of NSCLC cells by sponging miR-96-5p. EBioMedicine. 2019;44:182–193.
   PubMed Web of Science ®Google Scholar
• Yang F, Liu D-Y, Guo J-T, et al. Circular RNA circ-LDLRAD3 as a biomarker in diagnosis of pancreatic cancer. World J Gastroenterol. 2017;23(47):8345–8354. DOI:10.3748/wjg.v23.i47.8345.
   PubMed Web of Science ®Google Scholar
• Yao J, Zhang C, Chen Y, et al. Downregulation of circular RNA circ-LDLRAD3 suppresses pancreatic cancer progression through miR-137-3p/PTN axis. Life Sci. 2019;239:116871.
   PubMed Web of Science ®Google Scholar
• Chen S, Shi F, Zhang W, et al. miR-744-5p inhibits non-small cell lung cancer proliferation and invasion by directly targeting PAX2. Technol Cancer Res Treat. 2019;18:1533033819876913.
   Web of Science ®Google Scholar
• Halvorsen AR, Ragle Aure M, Õjlert ÅK, et al. Identification of microRNAs involved in pathways which characterize the expression subtypes of NSCLC. Mol Oncol. 2019;13(12):2604–2615. DOI:10.1002/1878-0261.12571.
   Web of Science ®Google Scholar
• Wang YF, Ao X, Liu Y, et al. MicroRNA-608 promotes apoptosis in non-small cell lung cancer cells treated with doxorubicin through the inhibition of TFAP4. Front Genet. 2019;10:809.
   PubMed Web of Science ®Google Scholar
• Wei C, Zhang R, Cai Q, et al. MicroRNA-330-3p promotes brain metastasis and epithelial-mesenchymal transition via GRIA3 in non-small cell lung cancer. Aging (Albany NY). 2019;11(17):6734–6761. DOI:10.18632/aging.102201.
   PubMedGoogle Scholar
• Fu Y, Yin Y, Peng S, et al. Small nucleolar RNA host gene 1 promotes development and progression of colorectal cancer through negative regulation of miR-137. Mol Carcinog. 2019;58(11):2104–2117. DOI:10.1002/mc.23101.
   Web of Science ®Google Scholar
• Chen R, Zhang Y, Zhang C, et al. miR-137 inhibits the proliferation of human non-small cell lung cancer cells by targeting SRC3. Oncol Lett. 2017;13(5):3905–3911.
   PubMed Web of Science ®Google Scholar
• Yang YR, Li Y-X, Gao X-Y, et al. MicroRNA-137 inhibits cell migration and invasion by targeting bone morphogenetic protein-7 (BMP7) in non-small cell lung cancer cells. Int J Clin Exp Pathol. 2015;8(9):10847–10853.
   PubMed Web of Science ®Google Scholar
• Li C, Wang Z, Zhang J, et al. Crosstalk of mRNA, miRNA, lncRNA, and circRNA and their regulatory pattern in pulmonary fibrosis. Mol Ther Nucleic Acids. 2019;18:204–218.
   PubMedGoogle Scholar
• Naser Al Deen N, AbouHaidar M, Talhouk R. Connexin43 as a tumor suppressor: proposed connexin43 mRNA-circularRNAs-microRNAs axis towards prevention and early detection in breast cancer. Front Med (Lausanne). 2019;6:192.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Zhang C, Ma J-X, et al. Circular RNA PIP5K1A promotes colon cancer development through inhibiting miR-1273a. World J Gastroenterol. 2019;25(35):5300–5309. DOI:10.3748/wjg.v25.i35.5300.
   PubMed Web of Science ®Google Scholar
• van Geldermalsen M, Wang Q, Nagarajah R, et al. ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer. Oncogene. 2016;35(24):3201–3208. DOI:10.1038/onc.2015.381.
   PubMed Web of Science ®Google Scholar
• Gkiouli M, Biechl P, Eisenreich W, et al. Diverse roads taken by (13)C-glucose-derived metabolites in breast cancer cells exposed to limiting glucose and glutamine conditions. Cells. 2019;8(10):1113.
   PubMed Web of Science ®Google Scholar
• Kappler M, Pabst U, Weinholdt C, et al. Causes and consequences of A glutamine induced normoxic HIF1 activity for the tumor metabolism. Int J Mol Sci. 2019;20(19):4742. DOI:10.3390/ijms20194742.
   Web of Science ®Google Scholar
• Ding J, Gou Q, Jin J, et al. Metformin inhibits PPARdelta agonist-mediated tumor growth by reducing Glut1 and SLC1A5 expressions of cancer cells. Eur J Pharmacol. 2019;857:172425.
   PubMed Web of Science ®Google Scholar
• Osman I, He X, Liu J, et al. TEAD1 (TEA domain transcription factor 1) promotes smooth muscle cell proliferation through upregulating SLC1A5 (Solute carrier family 1 member 5)-mediated glutamine uptake. Circ Res. 2019;124(9):1309–1322. DOI:10.1161/CIRCRESAHA.118.314187.
   PubMed Web of Science ®Google Scholar
• Zhuang X, Tong H, Ding Y, et al. Long noncoding RNA ABHD11-AS1 functions as a competing endogenous RNA to regulate papillary thyroid cancer progression by miR-199a-5p/SLC1A5 axis. Cell Death Dis. 2019;10(8):620. DOI:10.1038/s41419-019-1850-4.
   PubMed Web of Science ®Google Scholar
• Rajasinghe LD, Hutchings M, Gupta SV. Delta-tocotrienol modulates glutamine dependence by inhibiting ASCT2 and LAT1 Transporters in Non-Small Cell Lung Cancer (NSCLC) cells: a metabolomic approach. Metabolites. 2019;9(3):50.
   PubMed Web of Science ®Google Scholar
• Hassanein M, Qian J, Hoeksema MD, et al. Targeting SLC1a5-mediated glutamine dependence in non-small cell lung cancer. Int J Cancer. 2015;137(7):1587–1597. DOI:10.1002/ijc.29535.
   PubMed Web of Science ®Google Scholar
• Hassanein M, Hoeksema MD, Shiota M, et al. SLC1A5 mediates glutamine transport required for lung cancer cell growth and survival. Clin Cancer Res. 2013;19(3):560–570. DOI:10.1158/1078-0432.CCR-12-2334.
   PubMed Web of Science ®Google Scholar
• Ergun S, Güney S, Temiz E, et al. Significance of miR-15a-5p and CNKSR3 as novel prognostic biomarkers in non-small cell lung cancer. Anticancer Agents Med Chem. 2018;18(12):1695–1701.
   PubMed Web of Science ®Google Scholar
• Jiang S, Yan W, Wang SE, et al. Let-7 suppresses B cell activation through restricting the availability of necessary nutrients. Cell Metab. 2018;27(2):393–403. e4. DOI:10.1016/j.cmet.2017.12.007.
   PubMed Web of Science ®Google Scholar
• Luo M, Wu L, Zhang K, et al. miR-137 regulates ferroptosis by targeting glutamine transporter SLC1A5 in melanoma. Cell Death Differ. 2018;25(8):1457–1472. DOI:10.1038/s41418-017-0053-8.
   PubMed Web of Science ®Google Scholar
• Peng YK, Pu K, Su H-X, et al. Circular RNA hsa_circ_0010882 promotes the progression of gastric cancer via regulation of the PI3K/Akt/mTOR signaling pathway. Eur Rev Med Pharmacol Sci. 2020;24(3):1142–1151. DOI:10.26355/eurrev_202002_20165.
   PubMed Web of Science ®Google Scholar
• Sun X, Luo L, Gao Y. Circular RNA PVT1 enhances cell proliferation but inhibits apoptosis through sponging microRNA-149 in epithelial ovarian cancer. J Obstet Gynaecol Res. 2020;46(4):625–635.
   Web of Science ®Google Scholar
• Yao J, Zhang C, Chen Y, et al. Downregulation of circular RNA circ-LDLRAD3 suppresses pancreatic cancer progression through miR-137-3p/PTN axis. Life Sci. 2019;239:116871.
   PubMed Web of Science ®Google Scholar
• Lu Z, Wang M, Wu S, et al. MicroRNA-137-regulated AKT serine/threonine kinase 2 inhibits tumor growth and sensitizes cisplatin in patients with non-small cell lung cancer. Oncol Lett. 2018;16(2):1876–1884. DOI:10.3892/ol.2018.8823.
   PubMed Web of Science ®Google Scholar
• Wang X, Zhang G, Cheng Z, et al. Knockdown of LncRNA-XIST suppresses proliferation and TGF-beta1-induced EMT in NSCLC through the Notch-1 pathway by regulation of miR-137. Genet Test Mol Biomarkers. 2018;22(6):333–342. DOI:10.1089/gtmb.2018.0026.
   PubMed Web of Science ®Google Scholar
• Broer A, Gauthier-Coles G, Rahimi F, et al. Ablation of the ASCT2 (SLC1A5) gene encoding a neutral amino acid transporter reveals transporter plasticity and redundancy in cancer cells. J Biol Chem. 2019;294(11):4012–4026. DOI:10.1074/jbc.RA118.006378.
   PubMed Web of Science ®Google Scholar
• Lu J, Chen M, Tao Z, et al. Effects of targeting SLC1A5 on inhibiting gastric cancer growth and tumor development in vitro and in vivo. Oncotarget. 2017;8(44):76458–76467. DOI:10.18632/oncotarget.19479.
   PubMedGoogle Scholar
• Csanadi A, Oser A, Aumann K, et al. Overexpression of SLC1a5 in lymph node metastases outperforms assessment in the primary as a negative prognosticator in non-small cell lung cancer. Pathology. 2018;50(3):269–275. DOI:10.1016/j.pathol.2017.10.016.
   PubMed Web of Science ®Google Scholar
• Dong J, Xiao D, Zhao Z, et al. Epigenetic silencing of microRNA-137 enhances ASCT2 expression and tumor glutamine metabolism. Oncogenesis. 2017;6(7):e356. DOI:10.1038/oncsis.2017.59.
   PubMedGoogle Scholar